---
figid: PMC10929194__ijbsv20p1947g007
figtitle: Targeted treatment of CRC KRAS mutation is the cause of resistance to anti-EGFR
  treatment, as it leads to constitutive activation of the MAPK signaling pathway
  and activation of Warburg metabolism
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10929194
filename: PMC10929194__ijbsv20p1947g007.jpg
figlink: /pmc/articles/PMC10929194/figure/F7
number: F7
caption: Targeted treatment of CRC KRAS mutation is the cause of resistance to anti-EGFR
  treatment, as it leads to constitutive activation of the MAPK signaling pathway
  and activation of Warburg metabolism. (→promote; --| inhibit)
papertitle: Impact of KRAS mutation on the tumor microenvironment in colorectal cancer
reftext: Yiru Zhou, et al. Int J Biol Sci. 2024;20(5).
year: '2024'
doi: 10.7150/ijbs.88779
journal_title: International Journal of Biological Sciences
journal_nlm_ta: Int J Biol Sci
publisher_name: Ivyspring International Publisher
keywords: Colorectal cancer | KRAS mutation | Tumor microenvironment | Immunotherapy
automl_pathway: 0.9389714
figid_alias: PMC10929194__F7
figtype: Figure
redirect_from: /figures/PMC10929194__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10929194__ijbsv20p1947g007.html
  '@type': Dataset
  description: Targeted treatment of CRC KRAS mutation is the cause of resistance
    to anti-EGFR treatment, as it leads to constitutive activation of the MAPK signaling
    pathway and activation of Warburg metabolism. (→promote; --| inhibit)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - KRAS
  - NRAS
  - MTG1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - GPER1
  - MERTK
  - EPHB2
  - GDP
---
